Biogen Inc. buy Royal Bank of Canada
Start price
04.10.24
/
50%
€168.70
Target price
04.10.25
€245.41
Performance (%)
-32.31%
Price
15:36
€114.20
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is performing very badly with a performance of -32.31%. This prediction currently runs until 04.10.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.465% | 2.465% |
| iShares Core DAX® | -0.695% | 0.275% |
| iShares Nasdaq 100 | -0.520% | 3.779% |
| iShares Nikkei 225® | 0.870% | 1.365% |
| iShares S&P 500 | -0.737% | 3.346% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $292.00 to $269.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat